CytomX Therapeutics, Inc.

CytomX Therapeutics, Inc.

2.35
USD
+0.17
(+7.80%)
-0.44EPS
817.12MMarket Cap
Nov 05Next Earn

CytomX Therapeutics, Inc. Documents

Q4 FY2022 · Presentation

CytomX Therapeutics Inc - JPMorgan Healthcare Conference - Conference Call Deck · 35 pages

Read CytomX Therapeutics, Inc.'s results firsthand

Preview the first 2 pages of this presentation
Create a free account to start reading

Full documents are included with Professional

Q4 FY2022 documents